Low doses of AMPA exert anticonvulsant effects on pentylenetetrazol-kindled seizures

Pharmacology Biochemistry and Behavior

Volumn 70, Issue 2-3, 2001, Pages 421-426

  Becker, Axel ^b   Grecksch, Gisela ^a   Schroeder, Helmut ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NONE

Author keywords

AMPA; Epilepsy; Pentylenetetrazol kindling; Rat; Seizures

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AUTORECEPTOR; CYCLOTHIAZIDE; PENTETRAZOLE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG RESPONSE; DRUG SCREENING; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEIZURE;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; RECEPTORS, AMPA; SEIZURES;

ANIMALIA;

EID: 0035172911     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00628-1     Document Type: Article

References (37)

1. Response to repetitive stimulation of AMPA receptors in patches excised from fields CA1 and CA3 of the hippocampus
2. Effect of cyclothiazide on spontaneous miniature excitatory postsynaptic currents in rat hippocampal pyramidal cells
3. Neuropharmacology of AMPA and kainate receptors
4. NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation
5. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats
6. AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked
7. Excitatory amino acid receptors in epilepsy
8. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures
9. AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide
10. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures
11. The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures
12. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat
13. Therapeutic potential of AMPA receptor ligands in neurological disorders
14. Interactions between cyclothiazide and 2,3-benzodiazepines in vivo and in vitro
15. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy
16. Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area
17. Desensitization at NMDA and AMPA-kainate receptors
18. The effect of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates
19. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy
20. Evidence for a role of presynaptic AMPA receptors in the control of glutamate release in the rat forebrain
21. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: A dual-label microdialysis study
22. Interaction between NMDA and nonNMDA receptors in nonconvulsive epilepsy in the WAG/Rij inbred strain
23. The WAG/Rij rat model for nonconvulsive absence epilepsy: Involvement of nonNMDA receptors
24. Separation of quisqualate- and kainate-selective glutamate receptors in cultured neurons from the rat superior colliculus
25. Trans-ACDP and L-APB presynaptically inhibit excitatory glutamatergic transmission in the basolateral amygdala (BLA)
26. Therapeutic potential of excitatory amino acid antagonists: Channel blocker and 2,3-benzodiazepine
27. Excitatory amino acids and seizures
28. Role of AMPA and GluR5 kainate receptors in the mouse development and expression of amygdala kindling in the mouse
29. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy
30. Quisqualate activates a rapidly inactivating high conductance ion channel in hippocampal neurons
31. Kainate/AMPA receptor antagonists are anticonvulsant against the tonic hindlimb component of pentylenetetrazol-induced seizures in the developing rats
32. Cyclothiazide unmasks an AMPA-evoked release of arachidonic acid from cultured striatal neurones
33. Benzothiadiazides inhibit rapid glutamate receptor desensitisation and enhance glutamatergic synaptic currents
34. Release of glutamate and aspartate from CA1 synaptosomes: Selective modulation of aspartate release by ionotropic glutamate receptor ligands
35. Blockade of desensitisation augments quisqualate excitotoxicity in hippocampal neurons
36. Benzodiazepine recognition site associated with the non-NMDA glutamate receptor